Efavirenz Main Page

Medical Advocates
Efavirenz (Sustiva/Strocrin)

Main Page

New and Noteworthy
Atripla
FDA Alerts/ Label Revisions
Database of ARV Drug Interactions
Journal Data
Conference Data
Guidelines
Perinatal Data
Pediatric Data
ARV Drugs Main Page

ARV Drugs Main Page New/Newsworthy Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: July 19, 2008

Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

July 2008

Efavirenz in Human Breast Milk, Mothers', and Newborns' Plasma.
Schneider S, Peltier A, Gras A, et alJ Acquir Immune Defic Syndr. 2008 Jul 8.

FDA Alerts/Label Revisions

FULL-TEXT DOCUMENT
Sustiva (efavirenz) Package Insert Updated
US FDA January 13, 2007

Dear Healthcare Professional Letter
Sustiva (efavirenz): neural tube defects in infant s born to women with first trimester exposure::
Sustiva (efavirenz) labeling change from Pregnancy Category C to D
June 10, 2005

New Long-Term Data Provide Guidance On The Use Of Sustiva (efavirenz)
In HIV-Treatment-Naīve Patients :Package Insert to Include 168-Week Data
on Long-Term Durability, Safety and Tolerability
August 26,
Sustiva Labeling Revisions
August 17, 2004\

ARV Drugs Main Page New/Newsworthy Home Page

Efavirenz Main Page